current affair

Merck's Molnupiravir, the COVID-19 antiviral pill has been designed to introduce the errors into the genetic code of the virus that causes COVID-19. The oral antiviral treatment will be branded as ‘Lagevrio’ in Britain.

from Jagran Josh https://ift.tt/3COeavx
via IFTTT